Načítá se...

Promising therapies for treatment of nonalcoholic steatohepatitis

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) has become the most common etiology for abnormal aminotransferase levels and chronic liver disease. Its growing prevalence is largely linked to the presence of metabolic syndrome, particularly diabetes and insulin resistance. It is estimated th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert Opin Emerg Drugs
Hlavní autoři: Noureddin, Mazen, Zhang, Alice, Loomba, Rohit
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906104/
https://ncbi.nlm.nih.gov/pubmed/27501374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2016.1220533
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!